Archive

vol. 21 , issue 4
5 articles
2021-04-30
01
Jun
2021
Hepat Mon

Pre-transplant Psoas Muscle Density as a Ready-to-Use and Low-cost Predictor of Patient Survival After Liver Transplant

Valentina Rosa Bertuzzo, Matteo Renzulli * , Alfredo Clemente, Alessandro Cucchetti, Lorenzo Maroni, Giacomo Frascaroli, et al.
|
Final Published
|
26
Jun
2021
Hepat Mon

Fibroblast Growth Factor 21 Reduces Cholesterol-Induced Hepatic Fibrogenesis by Inhibiting TGF-β/Smad3C Signaling Pathway in LX2 Cells

Reza Afarin ORCID , Hossein Babaahmadi Rezaei , Hamid Yaghooti, Narges Mohammadtaghvaei ORCID *
|
Final Published
|
01
Jun
2021
Hepat Mon

A20 Attenuates Lipopolysaccharide-Induced Inflammation Through MAPK/ERK/JNK Pathway in LX-2 Cells

Xiaohan Wang * , Feng Han, Yueyu Shen, Yunqing Chen, Zizhong Ji
|
Final Published
|
02
Jun
2021
Hepat Mon

Treatment with Grazoprevir/Elbasvir in Post-kidney Transplant Patients with Hepatitis C Virus Genotype 4 Infection

Faisal Abaalkhail * , Waleed Al-hamoudi, Ibrahim Altraif, Hazem Mohamed, Hassan Aleid, Dieter Broering, et al.
|
Final Published
|
24
May
2021
Hepat Mon

Hepatic Epithelioid Hemangioendothelioma: A Review of Three Liver Transplant Recipients

Ghazaleh Shaker ORCID , Farid Azmoudeh-Ardalan ORCID , Ali Jafarian ORCID , Niloofar Ayoobi Yazdi ORCID , Masoomeh Safaei *
|
Final Published
|